A possible role for polymorphonuclear leucocytes in the defence against recrudescent herpes simplex virus infection in man.
We have used a 51Cr release assay to demonstrate that human polymorphonuclear leucocytes (PMNL) can damage herpes simplex infected target cells sensitized with antiviral antibody. Effective sensitizing antibodies were found in both serum and saliva of all those persons tested who were subject to recurrent cold sores. PMNL were much less effective as killer cells than peripheral blood mononuclear cells, but as they are the predominant inflammatory cell with the HSV1 lesion they may be, quantitatively, more important. The cytotoxic effects of both PMNL and mononuclear cells were significantly reduced by prostaglandin E1 as well as by several drugs that were tested. It is suggested that antibody dependent PMNL-mediated cytotoxicity may play a role in the human host defences against recrudescent herpes simplex infection.
D000914:Antibodies, Viral; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects; D003165:Complement System Proteins; D004306:Dose-Response Relationship, Immunologic; D006561:Herpes Simplex / Q000276:immunology*; D006801:Humans; D009504:Neutrophils / Q000276:immunology*; D011458:Prostaglandins E / Q000494:pharmacology; D012463:Saliva / Q000276:immunology
D000914:Antibodies, Viral; D011458:Prostaglandins E; D003165:Complement System Proteins